Xiaoxi Liu

Xiaoxi Liu

Auto-generated profile, based on publicly available information

Xiaoxi Liu

Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2019 in Genome Biology
Verified
Journal Article
Open access
PDF file
SKShunichi Kosugi
Shunichi Kosugi
YMYukihide Momozawa
Yukihide Momozawa
XLXiaoxi Liu
Xiaoxi Liu
CTChikashi Terao
Chikashi Terao
MKMichiaki Kubo
Michiaki Kubo
YKYoichiro Kamatani
Yoichiro Kamatani
Structural variations (SVs) or copy number variations (CNVs) greatly impact the functions of the genes encoded in the genome and are responsible for diverse human diseases. Although a number of existing SV detection algorithms can detect many types of SVs using whole genome sequencing (WGS) data, no single algorithm can call every type of SVs with high precision and high recall. We comprehensively evaluate the performance of 69 existing SV detection algorithms using multiple simulated and real WGS datasets. The results highlight a subset of algorithms that accurately call SVs depending on specific types and size ranges of the SVs and that accurately determine breakpoints, sizes, and genotypes of the SVs. We enumerate potential good algorithms for each SV category, among which GRIDSS, Lumpy, SVseq2, SoftSV, Manta, and Wham are better algorithms in deletion or duplication categories. To improve the accuracy of SV calling, we systematically evaluate the accuracy of overlapping calls between possible combinations of algorithms for every type and size range of SVs. The results demonstrate that both the precision and recall for overlapping calls vary depending on the combinations of specific algorithms rather than the combinations of methods used in the algorithms. These results suggest that careful selection of the algorithms for each type and size range of SVs is required for accurate calling of SVs. The selection of specific pairs of algorithms for overlapping calls promises to effectively improve the SV detection accuracy.

27 January 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
XLXiaoxi Liu
Xiaoxi Liu
AHAyaka Homma
Ayaka Homma
JSJamasb Sayadi
Jamasb Sayadi
SYShu Yang
Shu Yang
JOJun Ohashi
Jun Ohashi
TTToru Takumi
Toru Takumi
The CRISPR-Cas9 system has recently emerged as a versatile tool for biological and medical research. In this system, a single guide RNA (sgRNA) directs the endonuclease Cas9 to a targeted DNA sequence for site-specific manipulation. In addition to this targeting function, the sgRNA has also been shown to play a role in activating the endonuclease activity of Cas9. This dual function of the sgRNA likely underlies observations that different sgRNAs have varying on-target activities. Currently, our understanding of the relationship between sequence features of sgRNAs and their on-target cleavage efficiencies remains limited, largely due to difficulties in assessing the cleavage capacity of a large number of sgRNAs. In this study, we evaluated the cleavage activities of 218 sgRNAs using in vitro Surveyor assays. We found that nucleotides at both PAM-distal and PAM-proximal regions of the sgRNA are significantly correlated with on-target efficiency. Furthermore, we also demonstrated that the genomic context of the targeted DNA, the GC percentage and the secondary structure of sgRNA are critical factors contributing to cleavage efficiency. In summary, our study reveals important parameters for the design of sgRNAs with high on-target efficiencies, especially in the context of high throughput applications.

22 January 2010 in Journal of Human Genetics
Verified
Journal Article
Closed access
XLXiaoxi Liu
Xiaoxi Liu
YKYoshiya Kawamura
Yoshiya Kawamura
TSTakafumi Shimada
Takafumi Shimada
TOTakeshi Otowa
Takeshi Otowa
SKShinko Koishi
Shinko Koishi
TSTsukasa Sasaki
Tsukasa Sasaki

28 August 2015 in Autism Research
Verified
Journal Article
Closed access
PDF file
XLXiaoxi Liu
Xiaoxi Liu
TSTakafumi Shimada
Takafumi Shimada
TOTakeshi Otowa
Takeshi Otowa
YWYu‐Yu Wu
Yu‐Yu Wu
YKYoshiya Kawamura
Yoshiya Kawamura
SGSusan Shurfen Gau
Susan Shurfen Gau

19 June 2019 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
YMYukihide Momozawa
Yukihide Momozawa
YIYusuke Iwasaki
Yusuke Iwasaki
MHMakoto Hirata
Makoto Hirata
XLXiaoxi Liu
Xiaoxi Liu
YKYoichiro Kamatani
Yoichiro Kamatani
MKMichiaki Kubo
Michiaki Kubo
Genetic testing has been conducted in patients with prostate cancer (PCa) using multigene panels, but no centralized guidelines for genetic testing exist. To overcome this limitation, we investigated the demographic and clinical characteristics of patients with pathogenic variants. We sequenced eight genes associated with hereditary PCa in 7636 unselected Japanese patients with PCa and 12 366 male, cancer-free control individuals. We assigned clinical significance for all 1456 variants using the American College of Medical Genetics and Genomics guidelines and ClinVar. We compared the frequency of carriers bearing pathogenic variants between cases and control participants with calculated PCa risk in each gene and documented the demographic and clinical characteristics of patients bearing pathogenic variants. All statistical tests were two-sided. We identified 136 pathogenic variants, and 2.9% of patients and 0.8% of control individuals had a pathogenic variant. Association with PCa risk was statistically significant for variants in BRCA2 (P < .001, odds ratio [OR] = 5.65, 95% confidence interval [CI] = 3.55 to 9.32), HOXB13 (P < .001, OR = 4.73, 95% CI = 2.84 to 8.19), and ATM (P < .001, OR = 2.86, 95% CI = 1.63 to 5.15). We detected recurrent new pathogenic variants such as p.Gly132Glu of HOXB13. Patients with pathogenic variants were 2.0 years younger at diagnosis and more often had smoking and alcohol drinking histories as well as family histories of breast, pancreatic, lung, and liver cancers. This largest sequencing study of PCa heredity provides additional evidence supporting the latest consensus among clinicians for developing genetic testing guidelines for PCa.

1 September 2014 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
XLXiaoxi Liu
Xiaoxi Liu
TTToru Takumi
Toru Takumi